Buys
Open market- Shares
- +20,000
- Avg price
- $0.9032
- Total value
- +$18,065
Shaun Bagai - Chief Executive Officer, Director at RenovoRx, Inc.
Issuer-level insider activity
- Role
- Chief Executive Officer, Director
- Issuer ticker
- RNXT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Shaun Bagai in RenovoRx, Inc.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +20,000
- Share %
- 100%
- Total value
- +$18,065
Reported holdings for Shaun Bagai in RenovoRx, Inc.
Form 4 holding
Chief Executive Officer, Director
RenovoRx, Inc.
- Security class
- Common Stock
- Shares / value
- 313,357
- Estimated value
- $263,251
- Report date
- 20 Mar 2026
- Price
- $0.8401
- Ownership
- The Bagai Family Trust
Form 4 holding
Chief Executive Officer, Director
RenovoRx, Inc.
- Security class
- Common Stock
- Shares / value
- 50,983
- Estimated value
- $42,830
- Report date
- 20 Mar 2026
- Price
- $0.8401
- Ownership
- Direct
Form 4 holding
Chief Executive Officer, Director
RenovoRx, Inc.
- Security class
- Stock Option
- Shares / value
- 946,107
- Estimated value
- Report date
- 03 Apr 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Executive Officer, Director
RenovoRx, Inc.
- Security class
- Warrants
- Shares / value
- 12,150
- Estimated value
- Report date
- 20 Mar 2026
- Price
- Ownership
- The Bagai Family Trust
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Shaun Bagai in RenovoRx, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.